Evidence map›Paper›PMID 38878251›Full record

ReviewCurrent hypertension reports2024

Pediatric Blood Pressure and Cardiovascular Health in Adulthood.

Yaxing Meng, Jonathan P Mynard, Kylie J Smith, Markus Juonala, Elaine M Urbina, Teemu Niiranen, Stephen R Daniels, Bo Xi, Costan G Magnussen

Abstract readReview
In one paragraph

Review in Current hypertension reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yaxing MengBaker Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, VIC, 3004, Australia.
Jonathan P MynardHeart Research Group, Murdoch Children's Research Institute, Parkville, VIC, Australia.
Kylie J SmithBaker Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, VIC, 3004, Australia.
Markus JuonalaDivision of Medicine, Turku University Hospital, Turku, Finland.
Elaine M UrbinaHeart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Teemu NiiranenDepartment of Public Health Solutions, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Stephen R DanielsDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Bo XiDepartment of Epidemiology, School of Public Health, Shandong University, Jinan, China.
Costan G MagnussenBaker Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, VIC, 3004, Australia. Costan.Magnussen@baker.edu.au.

Funding

PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BRYAN C BERGMAN · 1995 to 2026
$32.6M
NIDDK NIH HHS P30 DK048520
6 · The paper itself

Abstract

purpose of reviewThis review summarizes current knowledge on blood pressure in children and adolescents (youth), with a focus on primary hypertension-the most common form of elevated blood pressure in this demographic. We examine its etiology, progression, and long-term cardiovascular implications. The review covers definitions and recommendations of blood pressure classifications, recent developments in measurement, epidemiological trends, findings from observational and clinical studies, and prevention and treatment, while identifying gaps in understanding and suggesting future research directions. RECENT

findingsYouth hypertension is an escalating global issue, with regional and national variations in prevalence. While the principles of blood pressure measurement have remained largely consistent, challenges in this age group include a scarcity of automated devices that have passed independent validation for accuracy and a generally limited tolerance for ambulatory blood pressure monitoring. A multifaceted interplay of factors contributes to youth hypertension, impacting long-term cardiovascular health. Recent studies, including meta-analysis and sophisticated life-course modelling, reveal an adverse link between youth and life-course blood pressure and subclinical cardiovascular outcomes later in life. New evidence now provides the strongest evidence yet linking youth blood pressure with clinical cardiovascular events in adulthood. Some clinical trials have expanded our understanding of the safety and efficacy of antihypertensive medications in youth, but this remains an area that requires additional attention, particularly regarding varied screening approaches. This review outlines the potential role of preventing and managing blood pressure in youth to reduce future cardiovascular risk. A global perspective is necessary in formulating blood pressure definitions and strategies, considering the specific needs and circumstances in low- and middle-income countries compared to high-income countries.

Indexed as

Blood PressureHypertensionAdolescentAdultAntihypertensive AgentsBlood Pressure DeterminationBlood Pressure Monitoring, AmbulatoryCardiovascular DiseasesChildHumansRisk FactorsAntihypertensive AgentsAdolescenceBlood pressureCardiovascular diseaseChildrenHypertensionPrevention

Identifiers

PMID38878251
PMCPMC11455673

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.